The Role and Responsibilities of the Clinical Research Coordinator

Slides:



Advertisements
Similar presentations
Investigator Responsibilities in Clinical Research
Advertisements

1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team.
CROMS NIDCR Clinical Monitoring
Tips to a Successful Monitoring Visit
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
HELP! The FDA is Coming! Margaret M. Groves, JD, CRA Director, Clinical Trials Quality Assurance (CTQA) School of Medicine (SOM) Compliance Office.
Managing Regulatory Documents Electronically
Research Coordination Guidance The Committees on Human Research Serving University of Vermont & Fletcher Allen Health Care
Common Mistakes & Audits 05/21/2014. Summary of audit findings by category.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
ROLE OF NURSES IN CLINICAL RESEARCH IN MALAWI OWEN DAIRE BSCN MPH RNM.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
Developed by Klinikos; Roy Fraser (2012) Investigator Study File
Determining % Effort for Clinical Trial Kathy Price, RN, MBA Manager, GI Clinical Research.
Stanley Estime, MSCI December 9, 2014 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
Clinical Trial Infrastructure in Centres Lillian L. Siu Princess Margaret Hospital.
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
Research and Development Protocol Submission and Continuing Review Processes Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas.
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
Planning and Surviving An Audit/Monitoring visit Carmen B. Jacobs, BS, RN,OCN, CCRP U.T. MD Anderson Cancer Center Houston, Texas U.S.A.
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
Monitoring, Audits, and Inspection Oh my! Rachel Sheppard Regulatory Director, OCRSS.
Common Audit Findings UTHSC Institutional Review Board (IRB)
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
Getting a study done at Jefferson:. Startup Activities: Image courtesy of CITI Program Clinical Research Coordinator course.
Stanley Estime, MSCI October 19, 2015 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
How to Start An Industry Sponsored Clinical Trial
Office of Human Research Protection Georgia Health Sciences University.
Sponsor Visits and Monitoring
Data Management – Regulatory Binder By: Johanna Park
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
Research Documentation Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
Responsibilities of Sponsor, Investigator and Monitor
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Supervisory Responsibilities of Clinical Investigators
Good Clinical Practice (GCP) and Monitoring Practices
PRCSG Training Webinar: Budget for Industry Sponsored Studies
Preparing for and Handling Monitoring Visits and Audits
Responsibilities of Sponsor, Investigator and Monitor
Study Feasibility and Start-up
MAINTAINING THE INVESTIGATOR’S SITE FILE
IRB reporting updates.
How to Handle FDA Audits
Data Management – Regulatory Binder
Alyssa Speier, MS, CIP November 13, 2013
Catherine Gregor, MBA, CCRC, CCRP CRC Workshop August 1, 2014
Regulatory Binder: Maintaining Essential Study Documentation
Elements of an Organized Regulatory Binder
Basics of Building and Understanding Data Collection Forms
ARCADIA Coordinator Webinar
Getting a Study Done at Jefferson:
MAINTAINING THE INVESTIGATOR’S STUDY FILE
TRTO (Translational Research Trials Office)
Responsibilities of the Principal Investigator
Understanding the Process of Documenting Informed Consent
Good clinical practice
Presentation transcript:

The Role and Responsibilities of the Clinical Research Coordinator Presented by: Alexandra Lansky, MD

I/we have no real or apparent conflicts of interest to report. Alexandra J. Lansky, MD I/we have no real or apparent conflicts of interest to report.

Clinical Research Coordinator Role and Responsibilities? The Clinical Research Coordinator (CRC) is responsible for conducting clinical trials using good clinical practice (GCP) under the auspices of the Principal Investigator (PI).

Reviewing a Potentially New Protocol Review New Protocol – Do you have the resources to do this study? Do you have the patient population to meet enrollment expectations? Do you have the equipment needed to conduct the study? Ultrasound CT Scan Lab Refrigerated Centrifuge -20 Degree Freezer; -70 Degree Freezer Dry Ice Space to store the devices? (Research devices will need to be stored in a locked limited access area)

IRB Submission Institutional Review Board Purpose - Will Review- Ethical conduct of the study Looks out for the patient Will Review- Protocol Instructions For Use (device directions) Investigational Drug Brochures Patient Informed Consent – is this document written at an 8th grade level? Patient Materials

Contracts and Budgets Contracts Budget Each protocol will have a contract Contracts will be reviewed by various individuals (organization specific) Budget Many coordinators will complete the budget Things to consider: Know the cost of procedures – review charge master What is considered research? Account for coordinators time for screening, enrolling, completing case report forms, IRB submissions, training, investigator meetings, etc.

Study Start Up Protocol Training – investigators, coordinators, departments that maybe impacted by the study Coordinator Training on data collection Setting up “Source Document Tools” Logging in investigational devices or drugs

Maintaining Regulatory Binders Each Study will have a Regulatory Binder. Binder includes: Protocol Device or Drug Information CVs and Licenses (must always be current) Lab Credentials (Normal Ranges, CAP, CLIA) Protocol Training Documents Delegation Logs Copies of ALL communications Consents IRB Communications Financial Disclosures

Consenting

Consenting Subjects Consent Form must be approved by the sponsor and the IRB Consent must be in the subject’s native language Subject should be given the opportunity to read the entire consent Subject should be given time to ask questions and have their questions answered to their satisfaction Subject should be given a copy of the signed consent form The consenting process should be clearly documented A copy of the consent should be part of the subjects medical record and part of their research chart

Screening Subjects Will need to Screen subjects for possible enrollment Subjects need to be consented before they can be screened Know protocol inclusion /exclusion Obtain protocol required labs – know study requirements Review medical history Review subject medications Review allergies

Enrolling Subjects The actual time of enrollment will be protocol specific Can be when the consent is signed and dated Can occur when the subject is randomized Can occur when the investigation device is inserted Other Document, Document, Document!! If it’s not documented it wasn’t done. All information collected for a study has to have a source document. Source documents need to be signed and dated! Subjects have the right to withdraw from the study at anytime

The Protocol “Nurse, get on the internet, go to Research Protocol.com, scroll down and click on the ‘Are you totally lost? icon.”

The Research Protocol The Research Protocol is the step by step “directions” for the conduct of the study. All steps need to be followed! If steps are missed, the coordinator will need to submit protocol deviations, more paper work! The protocol can be amended during the course of the study. If this occurs, the coordinator will need to notify the IRB of the amendment prior to the implementation of the amendment.

Documentation and Data Entry The coordinator will gather all source documents for data entry. Study data is submitted to the sponsor Electronically -eCRF Paper There are many electronic data systems that the coordinator will need to know how to use Data entered in many cases will be source verified by a study monitor If discrepancies are identified, queries will be submitted for data clarification Investigator reviews all data and signs all data forms

Device and Drug Accountability Study Devices and Study Medications Must be “logged” in by the coordinator Must be stored in a locked limited access area Must be logged as used Devices – must track expiration dates, lot numbers and serial numbers (device stickers) Drugs – Must track expiration dates, lot numbers and serial numbers Must track # of pills dispensed Pill containers and remaining medication must be returned at each scheduled visit to determine subject compliance

Subject Follow-Up Subject duration in a study can last from a day to a life time. The coordinator is responsible for making sure the subject complies with follow-up. If the coordinator can’t find a patient: Need to make 3 documented phone attempts Contact their physician to see if they have an alternative contact # Send a certified letter to the subject’s last know address Document, Document, Document! Search the Social Security Death Index

Reporting Adverse Events Whenever a subject is seen, the subject should be evaluated for possible adverse events. Adverse events are things that the subject reports that have occurred since they have entered the study. (nausea, headaches, chest pain, etc.) Serious Adverse Events will need to be reported in a timely manner to the study sponsor and the IRB.

Monitoring Visits Many studies will be routinely monitored to assure protocol compliance. Monitors will review: Consents Case Report Forms Regulatory Binders Device/Drug Accountability Coordinators and the Principal Investigator will need to meet with study monitors on a routine basis.

Study Closure The Coordinator will: Confirm all case report forms have been completed All queries have been answered All documents are signed All study documents have been filled All study specific devices/drugs have been returned to the sponsor or destroyed IRB has been notified of study closure Study documents have been archived

Thank you!